In this research, the obtained evidences support the hypothesis that gamma-aminobutyric acid (r-aminobutyric acid, GABA) can trap malondialdehyde (MDA) indirectly or directly. In vitro, reaction between GABA with fatty acid, which can be confirmed by detecting the formation and yield of MDA and the consumption of GABA, shows that GABA can trap the reactive intermediates during lipid peroxidation. Further study of the direct reaction between GABA and MDA indicated that GABA reacts readily with MDA under supraphysiological conditions to form different products. A nonfluorescent enamine (product 1) and a lipofuscin-like fluorescent 1,4-dihydropyridine (product 2) were obtained experimentally from reaction of equimolar of GABA+MDA and were detected by means of high performance liquid chromatography (HPLC) separation for the reaction mixtures at 48 h. We proposed a mechanism for the formation of these products from oxidation of polyunsaturated fatty acids (PUFA) to the reaction of GABA and MDA. The results suggest that the scavenging effects of GABA on reactive carbonyl compounds may play an important role in inhibiting the formation of advanced lipoxidation end products (ALEs), and GABA, as a potent antioxidant or additive, is a novel functional factor for nutraceuticals.
INTRODUCTION
Tissue deterioration and aging have been widely associated with the accumulation of chemical processes induced by lipid peroxidation and glycation, [1] [2] which are two critical biological side-reactions in the energy metabolism and lead to the formation of advanced glycation end-products (AGEs) and advanced lipoxidation end products (ALEs). These processes have been widely documented to be responsible for the formation of various age pigment-like fluorophores and many chronic diseases, such as chronic inflammatory diseases, [3] [4] neuronal degenerative diseases, and even physiological aging. [5] [6] [7] A variety of reactive carbonyl compounds derived from Maillard and lipid peroxidation reactions act as intermediates in the formation of AGEs and ALEs. [8] [9] These carbonyl compounds were found to react readily with an amino group of proteins giving rise to the formation of protein aggregates, resulting in protein structural and functional alterations. 10 -11 * Authors to whom correspondence should be addressed.
Malondialdehyde (MDA), at the level of 0.3-30 nmol/mL in human plasma under pathophysiological conditions, can target a variety of biological components, such as structural and functional proteins and nucleic acids. 5 MDA reacts with DNA bases to produce adducts to deoxyguanosine, deoxyadenosine and deoxycytidine. 12 MDA causes tissue injury and the depression of energy metabolism, thus representing biochemical markers for disease progression, such as chronic myeloid leukemia, 13 Huntington's disease.
14 Recent research results suggest that schizophrenic patients exhibit increased MDA levels, which leads to neuronal damage. 15 These findings further support a role of carbonyl injury in the pathogenesis and the potential benefits of antioxidant therapy.
GABA (r-aminobutyric acid, GABA) is a natural amino acid with wide occurrence. It has been shown that GABA exhibits anti-hypertensive effect, activates the blood flow and increases the oxygen supply in the brain to enhance metabolic function of brain cells. [16] [17] It was suggested that GABA can improve visual cortical function in senescent monkeys 18 and Kupperman syndrome, 19 and controll cardiovascular function. 20 Decreased proportion of GABA was associated with age-related degradation of neuronal function and neuronal degenerative diseases. [19] [20] [21] In this paper, it is hypothesized that GABA may inhibit the formation of ALEs and scavenge reactive carbonyl compounds such as MDA based on a potential carbonyl-amino reaction under physiological conditions.
MATERIALS AND METHODS

Materials
GABA (purity >99.0%) and diethylenetriaminepentaacetic acid (DTPA) were purchased from Sinopharm Chemical Reagent C., Ltd (Shanghai, China). O-phthaldialdehyde (OPA), 2-mercaptoethanol (MCE), thiobarbituric acid and 1,1,3,3-tetramethoxypropane (TMP) were obtained from Sigma-Aldrich (Shanghai, China). Arachidonic acid (AA) (purity >99.0%), linoleic acid (LA) (purity >99.0%), oleic acid (purity >99.0%) and other chemicals used were purchased from Huihong Chemical Reagent C., Ltd (Changsha, China).
Preparation
MDA stock solution (10 mM) was prepared by hydrolyzing TMP according to a method described by Kikugawa and Beppu. 22 0.084 mL (0.5 mmol) of TMP was added to 2 mL of 1.0 M HCl and shaken at 40 C for about 2 mins. After the TMP was fully hydrolyzed, the pH was adjusted to 7.4 with 6.0 M NaOH, and the stock solution was finally made up to 50 mL with 0.2 M phosphate buffer solution (PBS) (pH 7.4). The stock solution was checked by measuring absorbance at 266 nm using 266 = 31500 M −1 cm −1 .
In Vitro Incubation Experiments
GABA (2 mM) was incubated with AA, LA, or oleic acid (10 mM) in 5 mL of 0.2 M PBS at 37 C (pH 7.4), in 20-mL scintillation vials for 48 h at 37 C, in a shaking water bath. 23 Aliquots were removed from the aqueous phase and stored at −20 C until analyzed by high performance liquid chromatography (HPLC).
GABA (5.0 mM) was incubated with MDA (5.0 mM) in 5 mL of 0.2 M PBS at 37 C (pH 7.4). Samples were analyzed by HPLC or Liquid chromatography-mass spectrometry (LC-MS).
Effect of GABA on Oxidation of Fatty Acids
In case of polyunsaturated fatty acids (PUFA), oxidation and decomposition of LA and AA depended on endogenous metal ions as key catalysts in the phosphate buffer. Modification of the free amino group of GABA was measured by the OPA assay, using GABA as standard. Solution of pre-column derivatization was prepared: 25 mg of OPA was dissolved in 0.5 mL methanol and 5 mL 0.4 M borate buffer (pH 9.6), subsequently 40 L of 2-MCE was added to the mixture. The solution can be kept for 1 week at 4 C in the dark. Reversed-phase HPLC analysis of the samples was carried out on an Agilent 1200 HPLC system, using a C 18 analytical column (250 mm × 4 6 mm, 5 m). The wavelength used for measure the derivatives was 338 nm. The mobile phase consisted of solution A (1000 mL) (2.72 g sodium acetate in water and 0.2 mL triethylamine) (pH 7.2) and solution B (1.35% (w/w) sodium acetate and acetonitrile and methanol in 4/7/9 (v/v/v)). The flow rate was 0.7 mL/min, and the elution gradient was as follows: 0-4 min, 0.5-26% B; 4-8 min, kept in 26% B; 8-15 min, 26-100% B.
LA or oleic acid (5 mM) was oxidized alone or in the presence of GABA (1 mM), as described above. Aliquots were removed at 48 h; DTPA (1 mM) was added, and analyzed by measurement of thiobarbituric acid reacting substances (TBARs), using MDA as external standard. 23 
HPLC Analysis of the Incubation
Mixture of GABA with MDA Principal reaction products of equimolar of GABA (5.0 mM) + MDA (5.0 mM) were separated and analyzed with HPLC in 0.2 M PBS at 37 C for 10 min and 48 h. HPLC analytical column and system were described above. The mobile phase consisted of solution A (0.1% trifluoroacetic acid in water) and solution B (acetonitrile, 100%). The flow rate was 0.7 mL/min, and the elution gradient was as follows: 0-3 min, 100% A; 3-10 min, 20% B; 10-25 min, 50% B. Different eluted components were collected to further check UV absorption wavelength. Fluorescence spectra of the incubation mixture were characterized using a FL3-P-TCSPC spectrofluorimeter (JY, France). Incubation products were diluted to 1/40 with the same buffer before spectrofluorometric measurements.
LC/MS Analysis of the Incubation Products of GABA with MDA
The molecular weights of principal products of reaction between GABA and MDA were analyzed by LC/MS. The reaction was conducted by incubating GABA (5.0 mM) with MDA (5.0 mM) in 0.2 M PBS at 37 C for 48 h. The positive electrospray ionization mode was applied for detection. Separation was done by Agilent 1100 Series LC/MSD with a Zorbax Eclipse XDB-C 8 (150 mm × 4 6 mm, 5 m) analytical column under following conditions: solution A was 13 mM ammonium acetate (pH 5.0) and solution B was 100% methanol, the flow rate was 1.0 mL/min, and the elution gradient was as follows: 0-5 min, 2% B; 5-25 min, 60% B. The wavelength of the SPD-M10Avp diode array detector (DAD) was set at 236 nm. The ESI/MS source was set as follows: the drying gas temperature was maintained at 350 C; CID voltage was set at 110 eV; the flow rate of drying gas was 5 L/min; nebulizer pressure was 60 psi; scan mode was set as full scan and ion source was atmospheric-pressure chemical ionization (APCI). The ions used for selected ion monitoring were chosen by scanning in the positive ion mode from m/z: 50-1000.
RESULTS
GABA Inhibition of Advanced Lipoxidation Reactions
Oleate, AA or LA (10 mM) was oxidized alone or in the presence of GABA (2 mM) in order to study the interaction of GABA with products of lipid peroxidation in phosphate buffer at pH 7.4, relying on endogenous metal ions in the phosphate buffer to catalyze PUFA oxidation. 23 As shown in Figure 1 , it was observed that GABA incubated alone or in the presence of oleate unchanged over the 48 h incubation period. However, in the presence of LA and AA, GABA was gradually consumed, with about 40% GABA loss at 48 hours, based on HPLC analysis. The direct relationship of formation and yield of MDA and GABA consumption is showed in Table I . PUFA was solubilized in the presence and absence of GABA. Why the GABA consumption was more than the formation of MDA may be ascribed to that GABA traps reactive carbonyl intermediates such as MDA in the formation of ALEs. HPLC curves are shown in Figure 2 . Because the standard absorbance spectrum of MDA showed a peak at 266 nm under a neutral condition and a peak at 245 nm under an acidic condition while GABA has no absorption in the range of 200-400 nm, products should show a peak at ∼245 nm. In fact, MDA was detected with the retention time of 4.562 min (Fig. 2(A) ). Meanwhile, two other products were also observed near 245 nm by on-line spectra. By choosing wavelength, the first new product (product 1) was observed at 274 nm with the retention time of 4.367 min (Fig. 2(B) ). The second new product (product 2) displayed simultaneous ultraviolet absorbance at 231, 262 and 394 nm with the retention time of 8.519 min (Fig. 2(C) ). Product 1 did not show any fluorescence, while product 2 showed a stable lipofuscinlike blue (Ex. 395 nm/Em. 458 nm) fluorescence. The UV-absorption maxima and fluorescence Ex/Em values of MDA, GABA, product 1, and product 2 are shown in Table II .
Identification of Reaction Products of GABA with MDA by LC/MS
The reaction products were identified using LC/MS. After the mixture of GABA and MDA was incubated for about 48 h, a total ion current chromatogram (TIC) (Fig. 3(B) ) in comparison with a DAD chromatogram (Fig. 3(A) ) showed that the peak of product 1 was at 2.711 min. The mass spectrum corresponding to the retention time of product 1 was m/z 158.2 [M P1 + H] + (Fig. 3(C) ). Similarly, product 2, TIC shown in Figure 3(B) , was separated by HPLC and identified in DAD with a retention time of 12.838 min (Fig. 3(A) ). The mass spectrum corresponding to product 2 was m/z 238.2 [M P2 + H] + (Fig. 3(D) ). The possible molecular structures and reaction pathways of products 1 and 2 are illustrated in Figure 4 according to the molecular weight and the knowledge in the related research field. 5 22-23 The formation mechanism of product 2 was similar to that of other fluorescent dihydropyridine derivatives, which are clearly elaborated by Kikugawa and Beppu 22 and confirmatively reviewed by Esterbauer et al. 5 
DISCUSSION
GABA is widely applied as an additive. 16-17 19 It was demonstrated that Decreased proportion of GABA is associated with age-related degradation of neuronal function. 21 In neuronal degenerative diseases, carbonyl stress induced by oxidative stress and lipid peroxidation is an important mechanism of neuronal function deterioration. 24 MDA, an important unsaturated carbonyl product of lipid peroxidation, has been found largely responsible for cytopathological effects during oxidative stress of lipid peroxidation. 5 25 Studies of carbonyl toxicity provide clues to a profound nature of oxidative stress. Therefore, compounds acting as carbonyl scavengers may reduce detrimental effects of the aforementioned processes. 26 Here, GABA that was hypothesized as an antioxidant is thought to act as a nucleophilic trap for reactive carbonyl intermediates in ALEs formation. Indeed, studies on the interaction of GABA with products of lipid peroxidation (Fig. 1) and the relationship between the formation of detectable MDA the consumption of GABA (Table I) dicarboxyl compounds and MDA in lipoxidation reactions.
Thus, it appears that, by trapping carbonyl intermediates such as MDA in lipoxidation reactions, GABA inhibits the formation of ALEs.
Our results further demonstrate that GABA reacts readily with MDA under supraphysiological conditions. Separated using HPLC and analyzed using different techniques, a nonfluorescent compound, product 1, and a fluorescent compound, product 2, were identified in this reaction (Fig. 2) . It was shown that the maximum peak of product 1 was at 274 nm, whereas product 2 showed three peaks at 231, 262 and 394 nm, respectively ( Table II) . Considering that the UV-absorption of enamine showed maxima at about 271-280 nm in water, [27] [28] [29] dihydropyridine and dihydropyridine-pyri-dinium derivative showed three absorption maxima at about 235, 260, and 398 nm, [27] [28] [29] [30] and the produced fluorophore showed the typical ceroid/lipofuscin-like fluorescence (Ex. 310-395/Em. 395-460), 10 our products matched with the reported spectra very well. Furthermore, according to the molecular weight (Fig. 3) , the products 1 and 2 are considered to be an enamine derivative and an 1,4-dihydropyridine adduct, respectively. The molecular proportion of GABA:MDA was 1:1 in product 1, and 1:3 in product 2. Acetaldehyde may be formed due to high concentrations of MDA under certain conditions, 29 so one molecule of GABA reacts with two molecules of MDA and one molecule of acetaldehyde to form dihydropyridine adducts as reported similarly in literature. [31] [32] It is frequently reported 30 33 that MDA reacts with amino compounds to form fluorescent products such as dihydropyridinium derivatives. The results of the reaction mechanism of MDA with GABA are similar to the reaction of MDA or other reactive carbonyl compounds with other amine compounds listed in literature, such as Glucosamine, 24 dopamine and serotonin. 34 The reaction pathway proposed in Figure 4 involves the oxidation of LA or AA, 23 the formation of ALEs, 10 and the formation of reaction products of GABA with MDA. A number of other carboxylic acid amide derivatives may be formed during oxidation of PUFA as same as proposed by Onorato et al., 23 but analysis of the amide content should be testified (Fig. 4) . The overall observations were consistent with the hypothesis that GABA acts as a sacrificial nucleophile, trapping reactive intermediates (Fig. 4) . 23 In general, the obtained evidence supports the hypothesis that GABA, as an antioxidant, inhibits the formation of reactive carbonyl intermediates during oxidative stress and reacts with MDA to form different conjugated complexes, which can either be fluorescent or nonfluorescent. These data illustrate GABA having a novel function to scavenge endogenous and/or further extrinsic unsaturated reactive carbonyls by reacting with aldehydes such as MDA and, subsequently, the ability of GABA to inhibit the formation of AGEs and ALEs and/or detoxification. The molecular mechanism of the inhibition of GABA on carbonyl and/or oxidative stress may prove useful for limiting the increased chemical modification of tissue proteins and associated pathology in aging and chronic diseases, such as neuronal degenerative diseases, diabetes. Moreover, controlled release has been attracting more and more attentions from nanomedicine scientists. We believe GABA-encapsulated nanoparticles will enhance the potential nutraceutical function of GABA and this investigation is in progress.
